Effects of Ligands on Human Hair Follicles Grafted Onto SCID Mice
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00177099|
Recruitment Status : Completed
First Posted : September 15, 2005
Last Update Posted : November 13, 2006
|Condition or disease||Intervention/treatment||Phase|
|Alopecia||Drug: FK506, GP11046, GP11511||Phase 1|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||35 participants|
|Intervention Model:||Factorial Assignment|
|Masking:||None (Open Label)|
|Official Title:||Neurotrophic Effects of Immunophilin Ligands on Human Hair Follicles Grafted Onto Service Combined Immunodeficient (SCID) Mice|
|Study Start Date :||July 2003|
|Estimated Study Completion Date :||September 2004|
- The average number of terminal hairs per graft will be compared between the control and the treated group.
- The number of follicles in anagen, catagen and telogen per graft will be averaged for each group. The results will be compared between the control and the treated groups.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00177099
|United States, Minnesota|
|University of Minnesota|
|Minneapolis, Minnesota, United States, 55455|
|Principal Investigator:||Marna Ericson, Ph D||University of Minnesota - Clinical and Translational Science Institute|
|Principal Investigator:||Maria Hordinsky, MD||University of Minnesota - Clinical and Translational Science Institute|